Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous versus intravenous ketamine for closed reduction of nasal fracture
IRCT20191011045060N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ketamine, midazolam and fentanyl in nasal fracture (2 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoint: Pain scale. Started Oct 2019; status: completed.
02
Drugs
ketaminemidazolamfentanyl
03
Conditions
nasal fracture
Beyond the preview
Go deeper on IRCT20191011045060N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191011045060N1.